Pharmaceutical

CTO Europe 2023: Cancer clinical trials shift as sector...

Building on the increased adoption of digital trial capabilities due to the Cov...

Emergent wins $75m BARDA contact for anthrax vaccine

Emergent BioSolutions has secured a $75m contract for the acquisition of the FD...

Opinion: The next Census could undercount the number of...

About 20 million disabled people may be erased if the U.S. Census Bureau moves f...

New research supports potential link between low-level ...

New research supports potential link between low-level lead exposure and liver i...

STAT+: With biotech in a slump, the industry’s job mark...

With biotech in a slump, the industry’s job market is feeling crimped.

STAT+: With new trial data, a blockbuster therapy from ...

The inflammation-targeting therapy Dupixent improved symptoms for patients with ...

STAT+: Springworks wins FDA approval for drug to treat ...

The FDA on Monday approved the first treatment for people with desmoid tumors, a...

STAT+: Most clinical trials run in Canada failed to tak...

Just 3% of more than 3,700 studies run exclusively in Canada over a recent 10-ye...

STAT+: Pharmalittle: Bioscience job market is upside do...

Bioscience job postings have dropped from around 19,000 in February 2022 to 10,0...

A new algorithm unveils CRISPR ‘treasure trove’

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Sales of antibiotics for food-producing animals ...

Amid concerns over the use of medically important antibiotics given to food-prod...

Pandemic-related immunity gap in kids explains surge of...

In a Q&A, the acting director of the WHO’s department of epidemic and pandemic p...

Opinion: I grew up in one of Africa’s largest informal ...

I grew up in one of Africa’s largest informal settlements. Now I’m helping heal it.

Opinion: Hospices can’t handle the growing number of pa...

Hospices can’t handle the growing number of patients who need wound care.

STAT+: Antitrust lawsuit alleges UnitedHealth’s Optum p...

Emanate Health sued UnitedHealth's Optum, alleging the insurer pushed it to agre...

STAT+: Medtronic isn’t afraid of Wegovy’s potential to ...

Want to stay on top of the science and politics driving biotech today? Sign up t...